Michele Zell-Kanter. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Administration, OralAntidotes/administration & dosageAntidotes/therapeutic useHumansIntubation, GastrointestinalIsoniazid/poisoningPyridoxine/administration & dosagePyridoxine/therapeutic useStatus Epilepticus/chemically inducedStatus Epilepticus/drug therapyTabletsTime Factors
Substances: See more » AntidotesTabletsPyridoxineIsoniazid
Year: 2010 PMID: 21131815 DOI: 10.1097/PEC.0b013e3181fe9228
Source DB: PubMed Journal: Pediatr Emerg Care ISSN: 0749-5161 Impact factor: 1.454